Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21147078rdf:typepubmed:Citationlld:pubmed
pubmed-article:21147078lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C0349543lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C0596290lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C0521451lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:21147078lifeskim:mentionsumls-concept:C1567863lld:lifeskim
pubmed-article:21147078pubmed:dateCreated2011-1-24lld:pubmed
pubmed-article:21147078pubmed:abstractTextNovaeguinoside II is one of the newly found asterosaponins, which are a kind of steroidal glycosides extracted from starfish with an anti-tumor effect. In this study, we investigated the bioactivity of novaeguinoside II on human U87MG glioblastoma cells. The results showed that novaeguinoside II significantly suppresses U87MG cell proliferation in a time- and concentration-dependent manner. Flow cytometric analysis of DNA in U87MG cells showed that novaeguinoside II induces the prominent appearance of an S phase peak in the cell cycle that is suggestive of apoptosis that is identical to the result of an annexin V/PI assay. Fluorescence and electron microscopy revealed apoptotic change of U87MG cells. The electrophoresis of DNA showed a typical "ladder" that is consistent with apoptotic DNA fragmentation. Cytofluorometry showed a decreased mitochondrial transmembrane potential in novaeguinoside II-treated U87MG cells. Western blot showed that novaeguinoside II increased the expression of cytochrome-c and caspase-3 protein. The novel findings suggest that novaeguinoside II can induce apoptosis of U87MG cells by a mitochondrial apoptotic pathway.lld:pubmed
pubmed-article:21147078pubmed:languageenglld:pubmed
pubmed-article:21147078pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21147078pubmed:citationSubsetIMlld:pubmed
pubmed-article:21147078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21147078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21147078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21147078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21147078pubmed:statusMEDLINElld:pubmed
pubmed-article:21147078pubmed:monthFeblld:pubmed
pubmed-article:21147078pubmed:issn1872-6240lld:pubmed
pubmed-article:21147078pubmed:authorpubmed-author:ZhouJieJlld:pubmed
pubmed-article:21147078pubmed:authorpubmed-author:ChengGangGlld:pubmed
pubmed-article:21147078pubmed:authorpubmed-author:ZhangXiangXlld:pubmed
pubmed-article:21147078pubmed:authorpubmed-author:TangHai-FengH...lld:pubmed
pubmed-article:21147078pubmed:authorpubmed-author:ChengGuangGlld:pubmed
pubmed-article:21147078pubmed:copyrightInfoCopyright © 2010 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21147078pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21147078pubmed:day4lld:pubmed
pubmed-article:21147078pubmed:volume1372lld:pubmed
pubmed-article:21147078pubmed:ownerNLMlld:pubmed
pubmed-article:21147078pubmed:authorsCompleteYlld:pubmed
pubmed-article:21147078pubmed:pagination22-8lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:meshHeadingpubmed-meshheading:21147078...lld:pubmed
pubmed-article:21147078pubmed:year2011lld:pubmed
pubmed-article:21147078pubmed:articleTitleNovaeguinoside II inhibits cell proliferation and induces apoptosis of human brain glioblastoma U87MG cells through the mitochondrial pathway.lld:pubmed
pubmed-article:21147078pubmed:affiliationInstitute of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, People's Republic of China.lld:pubmed
pubmed-article:21147078pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21147078pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed